Obesity

•	Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data Qin L, Knol MJ, Corpeleijn E, Stolk RP Eur J Epidmiol. 2010;25(1):5-12
•	Obstructive sleep apnea among obese patients with type 2 diabetes Foster GD, Sanders MH, Millman R, et al, for the Sleep AHEAD Research Group Diabetes Care. 2009;32(6):1017-1019
•	Predictors and impact of intensification of antihyperglycemic therapy in type 2 diabetes: translating research into action for diabetes (TRIAD) McEwen LN, Bilik D, Johnson SL, et al ACC Abstracts of the 48th Scientific Session. 2009;32(6):971-976
•	Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study Kasper JS, Liu Y, Giovannucci E Int J Cancer. 2009;124(6):1398-403
•	Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population Shigetoh Y, Adachi H, Yamagishi S, et al Am J Hypertension.. 2009;22(2):151-155
•	Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006 Li C, Ford ES, Zhao G, Mokdad AH Diabetes Care. 2009;32(2):342-347
•	Impact of a weight management program on health-related quality of life in overweight adults with type 2 diabetes Williamson DA, Rejeski J, Lang W, Van Dorsten B, Fabricatore AN, Toledo K, for the Look AHEAD Research Group Arch Intern Med. 2009;169(2):163-171
•	Prevention of weight gain in adult patients with type 2 diabetes treated with pioglitazone Kushner RF, Sujak M Ophthalmology. 2009 Jan 29. [Epub ahead of print]
•	Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study Jakicic JM, Jaramillo SA, Balasubramanyam A, et al Int J Obesity. 2009 Jan 20. [Epub ahead of print]
•	Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW ACC Abstracts of the 48th Scientific Session. Cell Tissue Res. 2009;335(1):165-189.
•	Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone Derosa G, D'Angelo A, Salvadeo SA, et al Metabolism. 2008;57(11):1552-1557
•	Overweight Latino children and adolescents have marked endothelial dysfunction and subclinical vascular inflammation in association with excess body fat and insulin resistance Caballero AE, Bousquet-Santos K, Robles-Osorio L, et al Diabetes Care. 2008;31(3):576-582
•	Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis Horvath K, Jeitler K, Siering U, et al Arch Intern Med. 2008;168(6):571-580
•	Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. Savoye M, Shaw M, Dziura J, et al. JAMA. 2007 Jun 27; 297(24): 2697-704.
•	Adiposity compared with physical inactivity and risk of type 2 diabetes in women Rana JS, Li TY, Manson JE, Hu FB Diabetes Care. 2007;30:53-58
•	Impact of gastric bypass surgery on gut hormones and glucose homeostasis in type 2 diabetes Naslund E, Kral JG Diabetes. 2006;55(Suppl 2):S92-S97
•	Mechanisms linking obesity to insulin resistance and type 2 diabetes Kahn SE, Hull RL, Utzschneider KM Nature. 2006;444:840-846
•	Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus De Filippis E, Cusi K, Ocampo G, et al J Clin Endocrinol Metab. 2006;91:4903-4910
•	Combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: prevention of fluid retention Boden G, Homko C, Mozzoli M, Zhang M, Kresge K, Cheung P Diabetes. 2007;56:248-255
•	Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin Riddle MC, Henry RR, Poon TH, et al Diabetes/Metabolism Research and Reviews. 2006;22:483-491
•	Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P J Clin Endocrinol Metab. 2006;91:3553-3558
•	Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes Blonde L, Klein EJ, Han J, et al Diabetes, Obesity and Metabolism. 2006;8:436-447
•	Lipotoxicity versus adipotoxicity-The deleterious effects of adipose tissue on beta cells in the pathogenesis of type 2 diabetes Eldor R, Raz I Diabetes Res Clin Pract. 2006;74(2 Suppl):S3-S8
•	Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Guidone C, Manco M, Valera-Mora E, et al Diabetes. 2006;55:2025-2031
•	Effects of sibutramine treatment in obese adolescents: a randomized trial Berkowitz RI, Fujioka K, Daniels SR, et al, for the Sibutramine Adolescent Study Group Ann Intern Med. 2006;145:81-90
•	Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old Adams KF, Schatzkin A, Harris TB, et al N Engl J Med. 2006;355:763-778
•	Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus de Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H Diabetologia. 2006;49:2058-2067. Epub 2006 Jul 14
•	Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes Blonde L, Klein EJ, Han J, et al Diabetes, Obesity and Metabolism. 2006;8:436-447
•	Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population Nagaya T, Yoshida H, Takahashi H, Kawai M Diabet Med. 2005;22:1107-1111
•	Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V Metabolism. 2005;54:800-808
•	Impact of Obesity and the Metabolic Syndrome on Risk Factors in African American Stroke Survivors: A Report From the AAASPS Ruland S, Hung E, Richardson D, Misra S, Gorelick PB Arch Neurol. 2005;62:386-390
•	Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB Am J Clin Nutr. 2005;81:555-563
•	Prevalence of overweight and obesity among adults with diagnosed diabetes--United States, 1988-1994 and 1999-2002 Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep. 2004;53:1066-1068
•	A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES) Murata GH, Hoffman RM, Shah JH, Wendel CS, Duckworth WC Arch Intern Med. 2004;164:1445-1450
•	Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Kim C, Lau J Arch Intern Med. 2004;164:1395-1404
•	Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin Abbasi F, Chu JW, Lamendola C, et al Diabetes. 2004;53:585-590
•	Favorable Effects of Pioglitazone and Metformin Compared With Gliclazide on Lipoprotein Subfractions in Overweight Patients With Early Type 2 Diabetes Lawrence JM, Reid J, Taylor GJ, Stirling C, Reckless PD Diabetes Care. 2004;27:41-46
•	Effects of Pioglitazone Versus Diet and Exercise on Metabolic Health and Fat Distribution in Upper Body Obesity Shadid S, Jensen MD Diabetes Care. 2003;26:3148-3152
•	Identification of Subjects with Insulin Resistance and ß-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome Hanley AJG, Wagenknecht LE, D’Agostino, Jr. RB, Zinman B, Haffner SM Diabetes. 2003;52:2740-2747
•	Increases in Clinically Severe Obesity in the United States, 1986-2000 Sturm R Arch Intern Med. 2003;163:2146-2148
•	Measures of Obesity Are Associated With Vascular Stiffness in Young and Older Adults Wildman RP, Mackey RH, Bostom A, et al Hypertension. 2003;42:468-473
•	Elevated C-Reactive Protein Is a Risk Factor for the Development of Type 2 Diabetes in Japanese Americans Nakanishi S, Yamane K, Kamei N, et al Diabetes Care. 2003;26:2754-2757
•	National Surveillance for Type 2 Diabetes Mellitus in Taiwanese Children Wei J-N, Sung F-C, Lin C-C, et al JAMA. 2003;290:1345-1350
•	Enhanced Fat Oxidation Through Physical Activity Is Associated With Improvements in Insulin Sensitivity in Obesity Goodpaster BH, Katsiaras A, Kelley DE Diabetes. 2003;52:2191-2197
•	Increased Malonyl-CoA Levels in Muscle From Obese and Type 2 Diabetic Subjects Lead to Decreased Fatty Acid Oxidation and Increased Lipogenesis; Thiazolidinedione Treatment Reverses These Defects Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM Diabetes. 2006;55:2277-2285
•	Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Sattar N, Gaw A, Scherbakova O, et al Circulation. 2003;108:414-419
•	Prevalence and Characteristics of the Metabolic Syndrome in the San Antonio Heart and Framingham Offspring Studies Meigs JB, Wilson PWF, Nathan DM, D’Agostino, Sr. RB, Williams K, Haffner SM Diabetes. 2003;52:2160-2167
•	A Population Perspective on Diabetes Prevention. Whom Should We Target for Preventing Weight Gain? Burke JP, Williams K, Narayan KMV, Leibson C, Haffner SM, Stern MP Diabetes Care. 2003;26:1999-2004
•	Population Health Significance of Gestational Diabetes Cheung NW, Byth K Diabetes Care. 2003;26:2005-2009
•	Lifestyle Modification Improves Endothelial Function in Obese Subjects With the Insulin Resistance Syndrome Hamdy O, Ledbury S, Mullooly C, et al Diabetes Care. 2003;26:2119-2125
•	Characteristics of Patients With Type 2 Diabetes in México. Results From a Large Population-Based Nationwide Survey Aguilar-Salinas CA, Velazquez Monroy O, Gómez-Pérez FJ, et al Diabetes Care. 2003;26:2021-2026
•	Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes. The Atherosclerosis Risk in Communities Study Duncan BB, Schmidt MI, Pankow JS, et al Diabetes. 2003;52:1799-1805
•	A Flexible, Low-Glycemic Index Mexican-Style Diet in Overweight and Obese Subjects With Type 2 Diabetes Improves Metabolic Parameters During a 6-Week Treatment Period Jimenez-Cruz A, Bacardi-Gascon M, Turnbull WH, Rosales-Garay P, Severino-Lugo I Diabetes Care. 2003;26:1967-1970
•	Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors Iwaki M, Matsuda M, Maeda N, et al Diabetes. 2003;52:1655-1663
•	Expression of Peroxisome Proliferator-Activated Receptor-Gamma1 and Peroxisome Proliferator-Activated Receptor-Gamma2 in Visceral and Subcutaneous Adipose Tissue of Obese Women Giusti V, Verdumo C, Suter M, Gaillard RC, Burckhardt P, Pralong F Diabetes. 2003;52:1673-1676
•	Weight Loss-Induced Plasticity of Glucose Transport and Phosphorylation in the Insulin Resistance of Obesity and Type 2 Diabetes Williams KV, Bertoldo A, Kinahan P, Cobelli C, Kelley DE Diabetes. 2003;52:1619-1626
•	Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis Clark JM, Diehl AM JAMA. 2003;289:3000-3004
•	Minireview: Adiposity, Inflammation, and Atherogenesis Lyon CJ, Law RE, Hsueh WA Endocrinology. 2003;144:2195-2200
•	Childhood and Adolescent Obesity: Risk of Type 2 Diabetes and Cardiovascular Disease
•	Low Adiponectin Levels in Adolescent Obesity: A Marker of Increased Intramyocellular Lipid Accumulation Weiss R, Dufour S, Groszmann A, et al J Clin Endocrinol Metab. 2003;88:2014-2018
•	Longitudinal Changes in Risk Variables of Insulin Resistance Syndrome From Childhood to Young Adulthood in Offspring of Parents With Type 2 Diabetes: The Bogalusa Heart Study Srinivasan SR, Frontini MG, Berenson GS Metabolism. 2003;52:443-450
•	Television Watching and Other Sedentary Behaviors in Relation to Risk of Obesity and Type 2 Diabetes Mellitus in Women Hu FB, Li TY, Colditz GA, Willett WC, Manson JE JAMA. 2003;289:1785-1791
•	C-reactive Protein is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N Diabetes. 2002;51:1596-1600
•	Surgical Treatment of Severe Obesity With a Low-Pressure Adjustable Gastric Band: Experimental Data and Clinical Results in 625 Patients Ceelen W, Walder J, Cardon A, Van Renterghem K, Hesse U, El Malt M, Pattyn, P. Ann Surg.. 2003;237:10-16
•	Adiposity and Hyperinsulinemia in Indians Are Present at Birth Yajnik CS, Lubree HG, Rege SS, et al J Clin Endocrinol Metab. 2002;87:5575-5580
•	Leptin: A Review of its Peripheral Actions and Interactions Margetic S, Gazzola C, Pegg GG, Hill RA Int J Obesity. 2002;26:1407-1433
•	Apolipoprotein E Kinetics: Influence of Insulin Resistance and Type 2 Diabetes Bach-Ngohou K, Ouguerram K, Nazih H, et al Int J Obesity. 2002;26:1451-1458
•	The Relative Contributions of Birth Weight, Weight Change, and Current Weight to Insulin Resistance in Contemporary 5-Year-Olds Wilkin TJ, Metcalf BS, Murphy MJ, Kirkby J, Jeffery AN, Voss LD Diabetes. 2002;51:3468-3472
•	Fasting Plasma Ghrelin Levels Are Negatively Correlated With Insulin Resistance and PAI-1, but Not With Leptin, in Obese Children and Adolescents Ikezaki A, HosodaH , Ito K, et al Diabetes. 2002;51:3408-3411
•	Confirmation from the Framingham Heart Study: Being Overweight Carries Increased Risk for Hypertension, Cardiovascular Disease, Hypercholesterolemia, and Diabetes
•	Diabetes Contributes to Cholesterol Metabolism Regardless of Obesity Simonen PP, Gylling HK, Miettinen TA. Diabetes Care. 2002;25:1511-1515.
•	Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy: the Hoorn Study. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD, Polak BC. Diabetes Care. 2002;25:1320-1325.
•	UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes Adler AI, Stevens RJ, Neil A, et al. Diabetes Care. 2002;25:894-899
•	Type 2 Diabetes and Metabolic Syndrome in Filipina-American Women: A High-risk Nonobese Population Maria Rosario G. Araneta, PhD, Deborah L. Wingard, PhD and Elizabeth Barrett-Connor, MD Diabetes Care. 2002;25:494-499
•	Orosomucoid in Urine Predicts Cardiovascular and Over-All Mortality in Patients With Type II Diabetes Christansen Ms, Hommel E, Magid E, Feldt-Rasmussen B. Diabetologia. 2002;45:115-20
•	Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin Knowler WC, Barrett-Connor PH, Fowler SE, et al. N Engl J Med. 2002;246:393-403
•	Risk Factors for Diabetes Mellitus by Age and Sex: Results of the National Population Health Survey Choi BCK, Shi F Diabetologia. 2001;44:1221-1231
•	Protease Inhibitors and Atypical Antipsychotic Agents May Impair Glucose Tolerance
•	Five-year Post-marketing Experience With Acarbose
•	Obesity and Diabetes Continue to Increase in the United States
•	Prevalence of Diabetes and Obesity Continues to Increase in United States Mokdad AH, Ford ES, Bowman BA, et al. Diabetes Care. 2001;24:412.
•	Suppression of Nuclear Factor-B and Stimulation of Inhibitor B by Troglitazone: Evidence for an Anti-inflammatory Effect and a Potential Antiatherosclerotic Effect in the Obese Ghanim H, Garg R, Aljada A, et al. Endocrinology. 2001;86:1306-1312
•	Treating Hyperlipidemia in Diabetic Adults Is Predicted to Be Effective and Cost-effective in the Primary and Secondary Prevention of Cardiovascular Events
•	A New Hormone, Resistin, Is Secreted by Fat Cells, Impairs Insulin Sensitivity, and Is Counteracted by a Thiazolidinedione. Is It a Link Between Obesity and Diabetes?
•	Glucose Intolerance in Obese Adolescents with Polycystic Ovary Syndrome: Roles of Insulin Resistance and B-Cell Dysfunction and Risk of Cardiovascular Disease Arslanian SA, Lewy VD, Danadian K J Clin Endocrinol Metab. 2001;86:66-71
•	Ratio of Triglycerides to HDL Cholesterol Is an Indicator of LDL Particle Size in Patients With Type 2 Diabetes and Normal HDL Cholesterol Levels Boizel R, Benhamou PY, Lardy B, et al. Diabetes Care. 2000;23:1679-1685
•	Troglitazone Reduces Plasma TNF-alpha Levels As it Improves Insulin Sensitivity in Obese Diabetic Patients
•	Postchallenge Plasma Glucose and Glycemic Spikes are More Strongly Associated with Atherosclerosis than Fasting Glucose or HbA1c Level Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. Diabetes Care. 2000;23:1830-1834
•	Fasting Insulin Levels Influence Plasma Leptin Levels Independently from the Contribution of Adiposity: Evidence from Both a Cross-sectional and an Intervention Study Doucet E, St-Pierre S, Almeras N, et al. J Clin Endocrinol Metab. 2000;85:4231-4237
•	Moderate Consumption of Red Wine Does Not Increase Insulin Sensitivity in Obese Women
•	Preoperative Triglycerides Predict Post-coronary Artery Bypass Graft Survival in Diabetic Patients: A Sex Analysis Sprecher DL, Pearce GL, Park EM, et al. Diabetes Care. 2000;23:1648-1653
•	An Elevated Homocysteine Level May Be a Risk Factor for Diabetic Retinopathy
•	Muscle Glucose Uptake Is Effectively Activated by Ischemia in Type 2 Diabetic Subjects Niklasson M, Holmang A, Sjostrand M, et al. Diabetes. 2000;49:1178-1185
•	Sustained Weight Loss in Severely Obese Persons Seems to Lessen the Likelihood that Diabetes Will Develop, but Have No Effect on the Development of Hypertension
•	Some Agents Used by Diabetes Patients Are Found to Inhibit the Formation of the Advanced Glycation End Products Implicated in the Development of Diabetic Complications Rahbar S, et al. Clin Chimica Acta.. 2000;301:65-77
•	Contribution of Visceral Obesity to the Deterioration of the Metabolic Risk Profile in Men With Impaired Glucose Tolerance
•	Effectiveness of a Comprehensive Diabetes Lower-Extremity Amputation Prevention Program in a Predominantly Low-Income African-American Population Patout CA, Birke JA, Horswell R, et al. Diabetes Care. 2000;23:1339-1342
•	Effect of Training on Insulin Sensitivity of Glucose and Lipolysis in Human Adipose Tissue Stallknecht B, Larsen JJ, Mikines KJ, et al. Am J Physiol. 2000;279:E376-E385
•	Type 2 Diabetes and Maternal Family History: An Impact Beyond Slow Glucose Removal Rate and Fasting Hyperglycemia in Low-risk Individuals? Results From 22.5 Years of Follow-up of Healthy Nondiabetic Men
•	Treating Hyperlipidemia in Diabetic Adults Is Predicted to Be Effective and Cost-effective in the Primary and Secondary Prevention of Cardiovascular Events
•	Insulin Action and Insulin Resistance in Human Skeletal Muscle Zierath JR, Krook A, Wallberg-Henriksson H. Diabetologia. 2000;43:821-835
•	In Older Women, Abdominal Obesity Is a Better Predictor of Mortality Than Increased BMI or Waist Circumference
•	The Fetal and Childhood Growth of Persons Who Develop Type 2 Diabetes
•	Cardiologists Should Become as Familiar With Diabetes as They Are With Dyslipidemia and Hypertension King SB III, Kosinski AS, Guyton RA, et al. J Am Coll Cardiol. 2000;35:1116-1133
•	Impact of Diabetes on Coronary Artery Disease in Women and Men
•	Decreasing Incidence of Major Amputations in People With Diabetes
•	Relationship Between Regional Fat Distribution and Insulin Resistance
•	Age-Related Patterns of the Clustering of Cardiovascular Risk Variables of Syndrome X From Childhood to Young Adulthood in a Population Made Up of Black and White Subjects: the Bogalusa Heart Study
•	Dynamics of Insulin Secretion in Obesity and Diabetes
•	Asymptomatic Bacteriuria May Be Considered a Complication in Women With Diabetes
•	Obesity: A Risk Factor for CVD in Men Steinberg HO, Paradisi G, Cronin J, et al. Circulation. 2000;101:2040-2046
•	Subdivisions of Subcutaneous Abdominal Adipose Tissue and Insulin Resistance
•	On the Existence of an Adipoinsular Axis Kieffer TJ, Habener JF. Am J Physiol. 2000;278:E1-E14
•	Reduced B-Cell Compensation to the Insulin Resistance Associated With Obesity in Members of Caucasian Familial Type 2 Diabetic Kindreds
•	Phenotypic Characteristics Associated With Insulin Resistance in Metabolically Obese but Normal-Weight Young Women
•	Effects of Postmenopausal Hormone Replacement Therapy on Central Abdominal Fat, Glycemic Control, Lipid Metabolism, and Vascular Factors in Type 2 Diabetes
•	Influence of Low Density Lipoprotein (LDL) Subfraction Profile and LDL Oxidation on Endothelium-Dependent and Independent Vasodilation in Patients With Type 2 Diabetes
•	Overnight Lowering of Free Fatty Acids With Acipimox Improves Insulin Resistance and Glucose Tolerance in Obese Diabetic and Nondiabetic
•	Weight Change and Duration of Overweight and Obesity in the Incidence of Type 2 Diabetes
•	Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women With Impaired Glucose Tolerance
•	A Prospective Study of Risk Factors for Diabetic Foot Ulcer
•	The Thiazolidinedione Rosiglitazone (BRL-49653) Lowers Blood Pressure and Protects Against Impairment of Endothelial Function in Zucker Fatty Rats
•	Prospective Associations of Fasting Insulin, Body Fat Distribution, and Diabetes With Risk of Ischemic Stroke
•	Amputation Prevention by Vascular Surgery and Podiatry Collaboration in High-Risk Diabetic and Nondiabetic Patients. The Operation Desert Foot Experience
•	Black-White Differences in Risk of Developing Retinopathy Among Individuals With Type 2 Diabetes
•	Effect of Troglitazone on Body Fat Distribution in Type 2 Diabetic Patients
•	Comparison of Short-term Diet and Exercise on Insulin Action in Individuals With Abnormal Glucose Tolerance
•	Polymorphism in the 5"-Leader Cistron of the 2-Adrenergic Receptor Gene Associated With Obesity and Type 2 Diabetes
•	The Natural History of Macular Edema after Cataract Surgery in Diabetes
•	Insulin Sensitivity, Insulin Action, and Fibrinolysis Activity in Nondiabetic and Diabetic Obese Subjects
•	Association of Hormone Replacement Therapy and Carotid Wall Thickness in Women With and Without Diabetes
•	Impaired Glucose Tolerance, Type 2 Diabetes, and Carotid Wall Thickness
•	Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS)
•	Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.
•	Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study.
•	Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
•	Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women With Polycystic Ovary Syndrome
•	The Tactile Circumferential Discriminator - A New, Simple Screening Device to Identify Diabetic Patients at Risk of Foot Ulceration
•	Effect of Intensive Treatment of Diabetes on the Risk of Death or Renal Failure in NIDDM and IDDM
•	Clinical Research in Diabetes and Obesity
•	Per Patient Cost for Managing Complications of Diabetes Approaches $50,000 Over 30 Years Caro JJ, Ward AJ, O"Brien JA. Diabetes Care. 2002;25:476-481
•	CVD Is the Most Expensive Complication of Type 2 Diabetes Diabetes Care. 2002;25:482-486
•	Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. Dhindsa G, Bhatia R, Dhindsa M, Bhatia V. J Postgrad Med. 2004;50(2):140-4

Clinical Bridges, Secaucus, NJ
Clinical Bridges is a division of KnowledgePoint360 Group, LLC.
Copyright © 2009 Clinical Bridges. All rights reserved.
National Diabetes Education Initiative, Clinical Bridges, and
KnowledgePoint360 are trademarks of KnowledgePoint360 Group, LLC.

Disclaimer Statement - Privacy Statement